CLARITY PHARMACEUTICALS LTD - Announcements

Market Cap $2.169B Add to my watchlist

Healthcare

Clarity Pharmaceuticals Ltd is an Australia-based clinical-stage radiopharmaceutical... Clarity Pharmaceuticals Ltd is an Australia-based clinical-stage radiopharmaceutical company. The Company is focused on developing theranostic (therapy and imaging) products, based on its platform SAR Technology. It is progressing seven clinical trials with its three key products, SARTATE, SAR-bisPSMA, and SAR-Bombesin. SARTATE is developed for diagnosing, staging, and treating cancers that express somatostatin receptor 2 (SSTR2), including neuroblastoma and neuroendocrine tumors (NETs). SAR-bisPSMA is developed for diagnosing, staging, and treating cancers that express Prostate Specific Membrane Antigen (PSMA). SAR-Bombesin is developed for identifying and selecting patients for subsequent treatment of cancers that express a specific receptor called the gastrin releasing peptide receptor (GRPr), including breast cancer and prostate cancer. It has a diverse range of products in clinical trials, which address both large indications as well as rare and orphan indications of cancer.More

Race Oncology (ASX: RAC) is an ASX-listed clinical stage biopharmaceutical company with a dedicated mission to be at the heart of cancer care. WEBINAR: What investors should know about what it takes for ASX-listed companies to get medical developments...

Announcements

Filter Results

All Price Sensitive Only

CU6	Notice of Annual General Meeting/Proxy Form		18/10/24	1.35MB	Share
CU6	Cleansing Notice		17/10/24	248.9KB	Share
CU6	Application for quotation of securities - CU6		17/10/24	22.86KB	Share
CU6	Copper-67 SAR-bisPSMA updates	PRICE SENSITIVE	16/10/24	554.2KB	Share
CU6	Positive guidance from the US FDA on Phase III trial	PRICE SENSITIVE	14/10/24	427.24KB	Share
CU6	Michelle Parker Promoted to CEO	PRICE SENSITIVE	14/10/24	180.26KB	Share
CU6	Clinical Manufacturing Agreement for Cu-64 SAR-bisPSMA		08/10/24	186.78KB	Share
CU6	Change of Director's Interest Notices - AT CB CR TR MP		04/10/24	327.47KB	Share
CU6	Cleansing Notice		02/10/24	595.56KB	Share
CU6	Application for quotation of securities - CU6		02/10/24	44.59KB	Share
CU6	COBRA study selected as a Top-Rated Oral Presentation		01/10/24	217.89KB	Share
CU6	CORPORATE GOVERNANCE STATEMENT		30/09/24	639.19KB	Share
CU6	Appendix 4G		30/09/24	357.5KB	Share
CU6	Annual Report to shareholders		30/09/24	10.19MB	Share
CU6	Ceasing to be a substantial holder		26/09/24	633.83KB	Share
CU6	Notification regarding unquoted securities - CU6		24/09/24	20.21KB	Share
CU6	Date of Annual General Meeting		23/09/24	431.51KB	Share
CU6	Initial Director's Interest Notice - Parker		20/09/24	518.13KB	Share
CU6	Appointment of Executive Director to Clarity's Board		20/09/24	161.16KB	Share
CU6	Becoming a substantial holder		20/09/24	3.51MB	Share
CU6	Change of Director's Interest Notice - Robinson		18/09/24	207.74KB	Share
CU6	Cleansing Notice		18/09/24	248.85KB	Share
CU6	Application for quotation of securities - CU6		18/09/24	31.53KB	Share
CU6	Shareholder briefing - presentation	PRICE SENSITIVE	18/09/24	3.68MB	Share
CU6	SECuRE trial advances	PRICE SENSITIVE	12/09/24	497.7KB	Share
CU6	S&P DJI Announces September 2024 Quarterly Rebalance	PRICE SENSITIVE	06/09/24	145.4KB	Share
CU6	Cleansing Notice		04/09/24	248.37KB	Share
CU6	Application for quotation of securities - CU6		04/09/24	26.19KB	Share
CU6	Cleansing Notice		29/08/24	596.13KB	Share
CU6	Application for quotation of securities - CU6		29/08/24	17.48KB	Share
CU6	Final Director's Interest Notice - Rob Thomas		26/08/24	194.04KB	Share
CU6	Changes to Board of Directors and Management Team		26/08/24	223.37KB	Share
CU6	Preliminary Final Report	PRICE SENSITIVE	23/08/24	7.08MB	Share
CU6	FDA Fast Track Designation 64CU-SAR-bisPSMA	PRICE SENSITIVE	22/08/24	211.99KB	Share
CU6	Notification regarding unquoted securities - CU6		16/08/24	28.29KB	Share
CU6	Cleansing Notice		15/08/24	595.8KB	Share
CU6	Application for quotation of securities - CU6		15/08/24	20.07KB	Share
CU6	Change of Director's Interest Notice - Biggin		12/08/24	921.12KB	Share
CU6	Cleansing Notice		09/08/24	248.32KB	Share
CU6	Application for quotation of securities - CU6		09/08/24	25.67KB	Share
CU6	Change of Director's Interest Notice - Biggin		05/08/24	920.6KB	Share
CU6	Cleansing Notice		02/08/24	594.95KB	Share
CU6	Application for quotation of securities - CU6		02/08/24	17.48KB	Share
CU6	Change of Director's Interest Notice - Taylor		02/08/24	201.62KB	Share
CU6	Cleansing Notice		01/08/24	595.8KB	Share
CU6	Application for quotation of securities - CU6		01/08/24	28.58KB	Share
CU6	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/07/24	2.48MB	Share
CU6	Supply agreement for Ac-225 with TerraPower Isotopes	PRICE SENSITIVE	16/07/24	194.84KB	Share
CU6	Clarity Receives $10 million R&D Tax Incentive		24/06/24	181.64KB	Share
CU6	Cleansing Notice		20/06/24	595.87KB	Share
CU6	Application for quotation of securities - CU6		20/06/24	17.5KB	Share
CU6	Clarity Confirms No Supply Disruptions for Clinical Trials		07/06/24	177.52KB	Share
CU6	Cleansing Notice		05/06/24	595.89KB	Share
CU6	Application for quotation of securities - CU6		05/06/24	20.14KB	Share
CU6	Clarity strengthens Cu-64 network with new supply agreement	PRICE SENSITIVE	30/05/24	193.84KB	Share
CU6	Change of Director's Interest Notice - Rob Thomas		22/05/24	824.68KB	Share
CU6	Cleansing Notice		17/05/24	170.74KB	Share
CU6	Application for quotation of securities - CU6		17/05/24	19.92KB	Share
CU6	Cleansing Notice		03/05/24	595.8KB	Share
CU6	Application for quotation of securities - CU6		03/05/24	17.38KB	Share
CU6	Clarity to Present at 3 World Leading Conferences		03/05/24	242.69KB	Share
CU6	Change of Director's Interest Notice - Thomas		30/04/24	916.46KB	Share
CU6	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	30/04/24	6.45MB	Share
CU6	Complete response with Cu-67 SAR-bisPSMA	PRICE SENSITIVE	30/04/24	765.26KB	Share
CU6	Application for quotation of securities - CU6		29/04/24	17.41KB	Share
CU6	Successful Completion of Retail Entitlement Offer	PRICE SENSITIVE	24/04/24	194.84KB	Share
CU6	Change in substantial holding		15/04/24	825.9KB	Share
CU6	Cleaning Notice		15/04/24	595.23KB	Share
CU6	Application for quotation of securities - CU6		15/04/24	22.64KB	Share
CU6	Ceasing to be a substantial holder - Taylor		15/04/24	227.52KB	Share
CU6	Change in substantial holding - Cabbit Pty Ltd		15/04/24	427.02KB	Share
CU6	Cleansing Notice		08/04/24	229.67KB	Share
CU6	Application for quotation of securities - CU6		05/04/24	16.14KB	Share
CU6	Clarity enters into Clinical Supply Agreement		04/04/24	209.49KB	Share
CU6	Despatch of Retail Entitlement Offer Booklet	PRICE SENSITIVE	04/04/24	10.04MB	Share
CU6	Completion of Placement and Institutional Entitlement Offer	PRICE SENSITIVE	28/03/24	294.58KB	Share
CU6	Cleansing Notice		26/03/24	442.78KB	Share
CU6	Proposed issue of securities - CU6		26/03/24	28.97KB	Share
CU6	Investor Presentation	PRICE SENSITIVE	26/03/24	10.32MB	Share
CU6	Clarity launches $121 million equity raise	PRICE SENSITIVE	26/03/24	234.26KB	Share
CU6	Trading Halt	PRICE SENSITIVE	25/03/24	877.01KB	Share
CU6	First participant treated in the last dose escalation cohort	PRICE SENSITIVE	22/03/24	363.26KB	Share
CU6	Change of Director's Interest Notice		21/03/24	214.65KB	Share
CU6	Cleansing Notice		21/03/24	247.95KB	Share
CU6	Application for quotation of securities - CU6		21/03/24	17.93KB	Share
CU6	Theranostic prostate cancer trial advances to multi-dose	PRICE SENSITIVE	15/03/24	1.11MB	Share
CU6	Additional COBRA trial data results	PRICE SENSITIVE	06/03/24	814.06KB	Share
CU6	S&P DJI Announces March 2024 Quarterly Rebalance	PRICE SENSITIVE	01/03/24	120.24KB	Share
CU6	Correction to 2023 Annual Report		29/02/24	196.3KB	Share
CU6	Half Yearly Report and Accounts		29/02/24	12.23MB	Share
CU6	Appendix 4D	PRICE SENSITIVE	29/02/24	261.96KB	Share
CU6	Cleansing Notice		15/02/24	595.61KB	Share
CU6	Application for quotation of securities - CU6		15/02/24	17.56KB	Share
CU6	Initial COBRA results	PRICE SENSITIVE	15/02/24	887.35KB	Share
CU6	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/01/24	6.43MB	Share
CU6	Cleansing Notice		19/01/24	597.29KB	Share
CU6	Application for quotation of securities - CU6		19/01/24	26.7KB	Share
CU6	Application for quotation of securities - CU6		19/01/24	26.84KB	Share
CU6	Final Director's Interest Notice		16/01/24	1010.9KB	Share
CU6	Resignation of Non-Executive Directors		16/01/24	181.73KB	Share

CU6 Notice of Annual General Meeting/Proxy Form
18/10/24		1.35MB	Share
CU6 Cleansing Notice
17/10/24		248.9KB	Share
CU6 Application for quotation of securities - CU6
17/10/24		22.86KB	Share
CU6 Copper-67 SAR-bisPSMA updates
16/10/24	PRICE SENSITIVE	554.2KB	Share
CU6 Positive guidance from the US FDA on Phase III trial
14/10/24	PRICE SENSITIVE	427.24KB	Share
CU6 Michelle Parker Promoted to CEO
14/10/24	PRICE SENSITIVE	180.26KB	Share
CU6 Clinical Manufacturing Agreement for Cu-64 SAR-bisPSMA
08/10/24		186.78KB	Share
CU6 Change of Director's Interest Notices - AT CB CR TR MP
04/10/24		327.47KB	Share
CU6 Cleansing Notice
02/10/24		595.56KB	Share
CU6 Application for quotation of securities - CU6
02/10/24		44.59KB	Share
CU6 COBRA study selected as a Top-Rated Oral Presentation
01/10/24		217.89KB	Share
CU6 CORPORATE GOVERNANCE STATEMENT
30/09/24		639.19KB	Share
CU6 Appendix 4G
30/09/24		357.5KB	Share
CU6 Annual Report to shareholders
30/09/24		10.19MB	Share
CU6 Ceasing to be a substantial holder
26/09/24		633.83KB	Share
CU6 Notification regarding unquoted securities - CU6
24/09/24		20.21KB	Share
CU6 Date of Annual General Meeting
23/09/24		431.51KB	Share
CU6 Initial Director's Interest Notice - Parker
20/09/24		518.13KB	Share
CU6 Appointment of Executive Director to Clarity's Board
20/09/24		161.16KB	Share
CU6 Becoming a substantial holder
20/09/24		3.51MB	Share
CU6 Change of Director's Interest Notice - Robinson
18/09/24		207.74KB	Share
CU6 Cleansing Notice
18/09/24		248.85KB	Share
CU6 Application for quotation of securities - CU6
18/09/24		31.53KB	Share
CU6 Shareholder briefing - presentation
18/09/24	PRICE SENSITIVE	3.68MB	Share
CU6 SECuRE trial advances
12/09/24	PRICE SENSITIVE	497.7KB	Share
CU6 S&P DJI Announces September 2024 Quarterly Rebalance
06/09/24	PRICE SENSITIVE	145.4KB	Share
CU6 Cleansing Notice
04/09/24		248.37KB	Share
CU6 Application for quotation of securities - CU6
04/09/24		26.19KB	Share
CU6 Cleansing Notice
29/08/24		596.13KB	Share
CU6 Application for quotation of securities - CU6
29/08/24		17.48KB	Share
CU6 Final Director's Interest Notice - Rob Thomas
26/08/24		194.04KB	Share
CU6 Changes to Board of Directors and Management Team
26/08/24		223.37KB	Share
CU6 Preliminary Final Report
23/08/24	PRICE SENSITIVE	7.08MB	Share
CU6 FDA Fast Track Designation 64CU-SAR-bisPSMA
22/08/24	PRICE SENSITIVE	211.99KB	Share
CU6 Notification regarding unquoted securities - CU6
16/08/24		28.29KB	Share
CU6 Cleansing Notice
15/08/24		595.8KB	Share
CU6 Application for quotation of securities - CU6
15/08/24		20.07KB	Share
CU6 Change of Director's Interest Notice - Biggin
12/08/24		921.12KB	Share
CU6 Cleansing Notice
09/08/24		248.32KB	Share
CU6 Application for quotation of securities - CU6
09/08/24		25.67KB	Share
CU6 Change of Director's Interest Notice - Biggin
05/08/24		920.6KB	Share
CU6 Cleansing Notice
02/08/24		594.95KB	Share
CU6 Application for quotation of securities - CU6
02/08/24		17.48KB	Share
CU6 Change of Director's Interest Notice - Taylor
02/08/24		201.62KB	Share
CU6 Cleansing Notice
01/08/24		595.8KB	Share
CU6 Application for quotation of securities - CU6
01/08/24		28.58KB	Share
CU6 Quarterly Activities/Appendix 4C Cash Flow Report
31/07/24	PRICE SENSITIVE	2.48MB	Share
CU6 Supply agreement for Ac-225 with TerraPower Isotopes
16/07/24	PRICE SENSITIVE	194.84KB	Share
CU6 Clarity Receives $10 million R&D Tax Incentive
24/06/24		181.64KB	Share
CU6 Cleansing Notice
20/06/24		595.87KB	Share
CU6 Application for quotation of securities - CU6
20/06/24		17.5KB	Share
CU6 Clarity Confirms No Supply Disruptions for Clinical Trials
07/06/24		177.52KB	Share
CU6 Cleansing Notice
05/06/24		595.89KB	Share
CU6 Application for quotation of securities - CU6
05/06/24		20.14KB	Share
CU6 Clarity strengthens Cu-64 network with new supply agreement
30/05/24	PRICE SENSITIVE	193.84KB	Share
CU6 Change of Director's Interest Notice - Rob Thomas
22/05/24		824.68KB	Share
CU6 Cleansing Notice
17/05/24		170.74KB	Share
CU6 Application for quotation of securities - CU6
17/05/24		19.92KB	Share
CU6 Cleansing Notice
03/05/24		595.8KB	Share
CU6 Application for quotation of securities - CU6
03/05/24		17.38KB	Share
CU6 Clarity to Present at 3 World Leading Conferences
03/05/24		242.69KB	Share
CU6 Change of Director's Interest Notice - Thomas
30/04/24		916.46KB	Share
CU6 Quarterly Activities/Appendix 4C Cash Flow Report
30/04/24	PRICE SENSITIVE	6.45MB	Share
CU6 Complete response with Cu-67 SAR-bisPSMA
30/04/24	PRICE SENSITIVE	765.26KB	Share
CU6 Application for quotation of securities - CU6
29/04/24		17.41KB	Share
CU6 Successful Completion of Retail Entitlement Offer
24/04/24	PRICE SENSITIVE	194.84KB	Share
CU6 Change in substantial holding
15/04/24		825.9KB	Share
CU6 Cleaning Notice
15/04/24		595.23KB	Share
CU6 Application for quotation of securities - CU6
15/04/24		22.64KB	Share
CU6 Ceasing to be a substantial holder - Taylor
15/04/24		227.52KB	Share
CU6 Change in substantial holding - Cabbit Pty Ltd
15/04/24		427.02KB	Share
CU6 Cleansing Notice
08/04/24		229.67KB	Share
CU6 Application for quotation of securities - CU6
05/04/24		16.14KB	Share
CU6 Clarity enters into Clinical Supply Agreement
04/04/24		209.49KB	Share
CU6 Despatch of Retail Entitlement Offer Booklet
04/04/24	PRICE SENSITIVE	10.04MB	Share
CU6 Completion of Placement and Institutional Entitlement Offer
28/03/24	PRICE SENSITIVE	294.58KB	Share
CU6 Cleansing Notice
26/03/24		442.78KB	Share
CU6 Proposed issue of securities - CU6
26/03/24		28.97KB	Share
CU6 Investor Presentation
26/03/24	PRICE SENSITIVE	10.32MB	Share
CU6 Clarity launches $121 million equity raise
26/03/24	PRICE SENSITIVE	234.26KB	Share
CU6 Trading Halt
25/03/24	PRICE SENSITIVE	877.01KB	Share
CU6 First participant treated in the last dose escalation cohort
22/03/24	PRICE SENSITIVE	363.26KB	Share
CU6 Change of Director's Interest Notice
21/03/24		214.65KB	Share
CU6 Cleansing Notice
21/03/24		247.95KB	Share
CU6 Application for quotation of securities - CU6
21/03/24		17.93KB	Share
CU6 Theranostic prostate cancer trial advances to multi-dose
15/03/24	PRICE SENSITIVE	1.11MB	Share
CU6 Additional COBRA trial data results
06/03/24	PRICE SENSITIVE	814.06KB	Share
CU6 S&P DJI Announces March 2024 Quarterly Rebalance
01/03/24	PRICE SENSITIVE	120.24KB	Share
CU6 Correction to 2023 Annual Report
29/02/24		196.3KB	Share
CU6 Half Yearly Report and Accounts
29/02/24		12.23MB	Share
CU6 Appendix 4D
29/02/24	PRICE SENSITIVE	261.96KB	Share
CU6 Cleansing Notice
15/02/24		595.61KB	Share
CU6 Application for quotation of securities - CU6
15/02/24		17.56KB	Share
CU6 Initial COBRA results
15/02/24	PRICE SENSITIVE	887.35KB	Share
CU6 Quarterly Activities/Appendix 4C Cash Flow Report
31/01/24	PRICE SENSITIVE	6.43MB	Share
CU6 Cleansing Notice
19/01/24		597.29KB	Share
CU6 Application for quotation of securities - CU6
19/01/24		26.7KB	Share
CU6 Application for quotation of securities - CU6
19/01/24		26.84KB	Share
CU6 Final Director's Interest Notice
16/01/24		1010.9KB	Share
CU6 Resignation of Non-Executive Directors
16/01/24		181.73KB	Share

REFRESH

1 2 3

(20min delay)
Last $6.78		Change 0.270(4.15%)		Mkt cap ! $2.169B

Open	High	Low	Value	Volume
$6.63	$6.88	$6.60	$11.91M	1.752M

Buyers (Bids)

No.	Vol.	Price($)
1	1600	$6.77

Sellers (Offers)

Price($)	Vol.	No.
$6.80	2400	2

View Market Depth

No.	Vol.	Price($)
1	1600	6.770
1	7500	6.640
3	1054	6.600
1	5000	6.550
2	1400	6.510

Price($)	Vol.	No.
6.800	2400	2
6.850	4731	1
6.870	380	1
6.880	2042	3
6.900	2443	2

Last trade - 16.10pm 18/10/2024 (20 minute delay)


Last $6.74		Change 0.270 ( 4.39 %)
Open	High	Low	Volume
$6.61	$6.88	$6.61	166250
Last updated 15.59pm 18/10/2024 ?

CU6 (ASX) Chart

CLARITY PHARMACEUTICALS LTD - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories